{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:36:35Z","timestamp":1760852195937},"reference-count":21,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.ejphar.2005.07.033","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T13:03:42Z","timestamp":1127221422000},"page":"59-69","source":"Crossref","is-referenced-by-count":6,"title":["Novel neuroprotective effects with O-benzyl derivative of pralidoxime in soman-intoxicated rodents"],"prefix":"10.1016","volume":"521","author":[{"given":"Weng-Keong","family":"Loke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Kwoon","family":"Sim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Lin","family":"Go","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2005.07.033_bib1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1471-4159.2004.02708.x","article-title":"Voltammetric study of the control of striatal dopamine release by glutamate","volume":"91","author":"Borland","year":"2004","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.ejphar.2005.07.033_bib2","series-title":"Frontal\u2013subcortical Circuits in Psychiatric and Neurological Disorders","first-page":"65","article-title":"Neurochemistry of frontal\u2013subcortical circuits","author":"Bronstein","year":"2001"},{"key":"10.1016\/j.ejphar.2005.07.033_bib3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF00316437","article-title":"HI-6 therapy of soman and tabun poisoning in primates and rodents","volume":"63","author":"Hamilton","year":"1989","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.ejphar.2005.07.033_bib4","first-page":"51","article-title":"A CIOMS ethical code for animal experimentation","volume":"39","author":"Howard-Jones","year":"1985","journal-title":"WHO Chronicals"},{"key":"10.1016\/j.ejphar.2005.07.033_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1600-0773.1988.tb00932.x","article-title":"Allosteric stabilisation of 3H-N-methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication","volume":"63","author":"Jepsen","year":"1988","journal-title":"Pharmacology and Toxicology"},{"key":"10.1016\/j.ejphar.2005.07.033_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00292614","article-title":"Reversible and irreversible inhibition of rat brain muscarinic receptors is related to different substitutions on bisquaternary pyridinium oximes","volume":"58","author":"Kloog","year":"1985","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.ejphar.2005.07.033_bib7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0014-2999(02)01548-0","article-title":"O-substituted derivatives of pralidoxime: muscarinic properties and protection against soman pressor effects in rats","volume":"442","author":"Loke","year":"2002","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.ejphar.2005.07.033_bib8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0149-7634(96)00050-4","article-title":"Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology","volume":"21","author":"McDonough","year":"1997","journal-title":"Neuroscience and Biobehavioural Reviews"},{"issue":"3","key":"10.1016\/j.ejphar.2005.07.033_bib9","first-page":"381","article-title":"Neural lesions in the rat and their relationship to EEG delta activity following seizures induced by the nerve agent soman","volume":"19","author":"McDonough","year":"1998","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ejphar.2005.07.033_bib10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1600-0773.1982.tb01027.x","article-title":"Modification of rat brain 5-hydroxytryptamine metabolism by sublethal doses of organophosphate agents","volume":"51","author":"Prioux-Guyonneau","year":"1982","journal-title":"Acta Pharmacologica et Toxicologica"},{"issue":"4","key":"10.1016\/j.ejphar.2005.07.033_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/(SICI)1099-1263(199707)17:4<255::AID-JAT441>3.0.CO;2-D","article-title":"Neurochemical mechanisms in soman-induced seizures","volume":"17","author":"Shih","year":"1997","journal-title":"Journal of Applied Toxicology"},{"key":"10.1016\/j.ejphar.2005.07.033_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0378-4274(91)90128-S","article-title":"A comparison of cholinergic effects of hi-6 and pralidoxime-2-chloride (2-PAM) in soman poisoning","volume":"55","author":"Shih","year":"1991","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.ejphar.2005.07.033_bib13","first-page":"86","article-title":"Anticonvulsants for soman-induced seizure activity","volume":"6","author":"Shih","year":"1999","journal-title":"Journal of Biomedical Science"},{"issue":"1","key":"10.1016\/j.ejphar.2005.07.033_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0091-3057(98)00243-3","article-title":"Preliminary evidence for an involvement of the cholinergic system in the sedative effects of rolipram in rats","volume":"64","author":"Silvestre","year":"1999","journal-title":"Pharmacology, Biochemistry and Behaviour"},{"issue":"6","key":"10.1016\/j.ejphar.2005.07.033_bib15","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0006-2952(92)90490-A","article-title":"Discovery of a novel soluble form of monoamine oxidase in the rat brain","volume":"43","author":"Sim","year":"1992","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.ejphar.2005.07.033_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0920-1211(93)90014-X","article-title":"Pharmacological dissociation of the motor and electrical aspects of convulsive status epilepticus induced by the cholinesterase inhibitor soman","volume":"14","author":"Sparenborg","year":"1993","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.ejphar.2005.07.033_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0920-1211(90)90065-4","article-title":"A progressive sequence of electroencephalographic changes during generalised convulsive status epilepticus","volume":"5","author":"Treiman","year":"1990","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.ejphar.2005.07.033_bib18","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s002040050340","article-title":"Pharmacological effects of oximes: how relevant are they?","volume":"70","author":"van Helden","year":"1996","journal-title":"Archives of Toxicology"},{"issue":"15","key":"10.1016\/j.ejphar.2005.07.033_bib19","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1523\/JNEUROSCI.22-15-06347.2002","article-title":"Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1\u2013M5 muscarinic receptor knock-out mice","volume":"22","author":"Zhang","year":"2002","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.ejphar.2005.07.033_bib20","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/(SICI)1096-9861(19970224)378:4<468::AID-CNE3>3.0.CO;2-0","article-title":"Anatomical localization and time course of Fos expression following soman-induced seizures","volume":"378","author":"Zimmer","year":"1997","journal-title":"The Journal of Comparative Neurology"},{"issue":"10","key":"10.1016\/j.ejphar.2005.07.033_bib21","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1523\/JNEUROSCI.18-10-03897.1998","article-title":"Nerve gas-induced seizures: role of acetylcholine in the rapid induction of Fos and glial fibrillary acidic protein in piriform cortex","volume":"18","author":"Zimmer","year":"1998","journal-title":"The Journal of Neuroscience"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905007624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905007624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,24]],"date-time":"2019-03-24T17:53:40Z","timestamp":1553450020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299905007624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":21,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0014299905007624"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2005.07.033","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}